PATENT CLAIM ANALYSIS

Application Number: 16270348
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "217010"]

Abstract:
This invention relates to methods and formulations for treating metabolic disorders and depression. In some embodiments, the methods comprise administering a dopamine receptor agonist and an anti-depressant.

Claim (Index 30):
The method of  claim 28  wherein the dopamine agonist is a D2 dopamine agonist.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15809851', '13774739', '14814018', '15874430', '13375810']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8360975850336594
- 35 USC 102 Novelty (BERT): 0.5539444593111841
- Combined Prediction Score: 0.8078822724614119
- Mean Citation Score: 363.02554
- Max Citation Score: 427.27103
- Similarity Product: 324.34585323874586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test